For most optometrists, visual electrophysiology testing has been considered the last test to turn to when a patient presents with unexplained vision loss. However, the increased accessibility of ...
The site's new homepage has a clean, clear design that enables visitors to quickly find the section of the site that most applies to them. The “News and Events” section gives visitors a quick look at ...
Please provide your email address to receive an email when new articles are posted on . ATLANTA — Diopsys will introduce a test for improving the sensitivity of current optical coherence tomography ...
According to literature, current algorithms in OCT technology may overstate the RNFL thickness due to patient physiology and other test related limitations. The Diopsys ® CORDA™ software utilizes ...
SEATTLE, Sept. 10, 2020 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company creating a photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it is ...
PINE BROOK, N.J., Oct. 09, 2018 /PRNewswire-PRWeb/ -- Diopsys Inc, the world leader in modern visual electrophysiology, announces the release of the Diopsys® Chromatic Flash Vision Screener, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results